InspireMD Announces Presentation of Positive One-Year
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection...
Source: globenewswire.com
Chuck Padala News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chuck Padala. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chuck Padala Today - Breaking & Trending Today
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
All pharmacokinetic endpoints were achieved, with a PK profile consistent with drug delivery and absorption in the colonAll NaviCap™ devices perfo...
Source: businessinsider.com
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing ...
All pharmacokinetic endpoints were achieved, with a PK profile consistent with drug delivery and absorption in the colon
Source: eagletribune.com
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
TEL AVIV, Israel and MIAMI, April 03, 2024 -- InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today announced that Marvin Slosman, Chief...
Source: marketscreener.com
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
TEL AVIV, Israel and MIAMI, March 26, 2024 -- InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today announced that an abstract of the...
Source: marketscreener.com